With small and medium-sized pharmaceutical companies facing increased scrutiny from global regulators due to recurring lapses, the Narendra Modi government is planning to handhold these drugmakers. The central government has designed “capacity-building workshops” to assist drugmakers in navigating the regulatory requirements effectively. The concept of the workshop was proposed by the Ministry of Commerce and Industry’s pharmaceutical export wing, Pharmexcil, which has been working with the Ministry of Health and Family Welfare to improve the good manufacturing practices of MSME drugmakers. The workshop will be conducted in collaboration with the country’s apex drug regulatory agency, the Central Drugs Standard Control Organization (CDSCO), an arm under the Health Ministry which regulates the quality and standard of drugs in India.
With small and medium-sized pharmaceutical companies facing increased scrutiny from global regulators due to recurring lapses, the Narendra Modi government is planning to handhold these drugmakers. The central government has designed “capacity-building workshops” to assist drugmakers in navigating the regulatory requirements effectively. The concept of the workshop was proposed by the Ministry of Commerce and Industry’s pharmaceutical export wing, Pharmexcil, which has been working with the Ministry of Health and Family Welfare to improve the good manufacturing practices of MSME drugmakers. The workshop will be conducted in collaboration with the country’s apex drug regulatory agency, the Central Drugs Standard Control Organization (CDSCO), an arm under the Health Ministry which regulates the quality and standard of drugs in India.